- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hidradenitis suppurativa (HS)
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 547KB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 94KB)
Secukinumab – November 2023
Secukinumab: Solution for injection 300 mg in 2 mL pre-filled syringe, Solution for injection 150 mg in 1 mL pre-filled syringe, Solution for injection 150 mg in 1 mL pre-filled pen, Solution for injection 300 mg in 2 mL pre-filled pen; Cosentyx®
Last updated
1 March 2024
